IBB vs. LFSC
Compare and contrast key facts about iShares Nasdaq Biotechnology ETF (IBB) and F/m Emerald Life Sciences Innovation ETF (LFSC).
IBB and LFSC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001. LFSC is an actively managed fund by F/m Investments. It was launched on Oct 30, 2024.
Performance
IBB vs. LFSC - Performance Comparison
Loading graphics...
IBB vs. LFSC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 0.12% | 27.98% | -5.72% |
LFSC F/m Emerald Life Sciences Innovation ETF | -4.45% | 56.54% | -6.02% |
Returns By Period
In the year-to-date period, IBB achieves a 0.12% return, which is significantly higher than LFSC's -4.45% return.
IBB
- 1D
- 4.32%
- 1M
- -3.65%
- YTD
- 0.12%
- 6M
- 17.17%
- 1Y
- 32.33%
- 3Y*
- 9.65%
- 5Y*
- 2.46%
- 10Y*
- 6.84%
LFSC
- 1D
- 6.16%
- 1M
- -3.82%
- YTD
- -4.45%
- 6M
- 17.66%
- 1Y
- 55.83%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IBB vs. LFSC - Expense Ratio Comparison
IBB has a 0.47% expense ratio, which is lower than LFSC's 0.54% expense ratio.
Return for Risk
IBB vs. LFSC — Risk / Return Rank
IBB
LFSC
IBB vs. LFSC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and F/m Emerald Life Sciences Innovation ETF (LFSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IBB | LFSC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.35 | 1.93 | -0.57 |
Sortino ratioReturn per unit of downside risk | 1.91 | 2.65 | -0.73 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.33 | -0.08 |
Calmar ratioReturn relative to maximum drawdown | 2.41 | 3.20 | -0.79 |
Martin ratioReturn relative to average drawdown | 8.61 | 8.96 | -0.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| IBB | LFSC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.35 | 1.93 | -0.57 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.11 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.94 | -0.68 |
Correlation
The correlation between IBB and LFSC is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
IBB vs. LFSC - Dividend Comparison
IBB's dividend yield for the trailing twelve months is around 0.23%, while LFSC has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
LFSC F/m Emerald Life Sciences Innovation ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
IBB vs. LFSC - Drawdown Comparison
The maximum IBB drawdown since its inception was -62.85%, which is greater than LFSC's maximum drawdown of -29.74%. Use the drawdown chart below to compare losses from any high point for IBB and LFSC.
Loading graphics...
Drawdown Indicators
| IBB | LFSC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.85% | -29.74% | -33.11% |
Max Drawdown (1Y)Largest decline over 1 year | -11.65% | -16.25% | +4.60% |
Max Drawdown (5Y)Largest decline over 5 years | -39.82% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -39.82% | — | — |
Current DrawdownCurrent decline from peak | -4.88% | -11.08% | +6.20% |
Average DrawdownAverage peak-to-trough decline | -21.30% | -8.25% | -13.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.47% | 5.80% | -2.33% |
Volatility
IBB vs. LFSC - Volatility Comparison
The current volatility for iShares Nasdaq Biotechnology ETF (IBB) is 8.62%, while F/m Emerald Life Sciences Innovation ETF (LFSC) has a volatility of 10.35%. This indicates that IBB experiences smaller price fluctuations and is considered to be less risky than LFSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| IBB | LFSC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.62% | 10.35% | -1.73% |
Volatility (6M)Calculated over the trailing 6-month period | 14.53% | 19.97% | -5.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.08% | 29.24% | -5.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.87% | 29.31% | -7.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.37% | 29.31% | -5.94% |